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Background. To test the hypothesis that varicella-zoster virus 
(VZV) infection contributes to temporal arteritis pathogenesis, 
comprehensive in situ analysis was performed on temporal ar-
tery biopsies of 38 anterior ischemic optic neuropathy (AION) 
patients, including 14 (37%) with giant cell arteritis. 
Methods. Biopsies were completely sectioned, and, on av-
erage, 146 serial sections per patient were stained for VZV gly-
coprotein E. 
Results. Four of 38 AION patients showed VZV glyco-
protein E staining, but VZV infection was not confirmed by 
staining for VZV IE63 protein and VZV-specific polymerase 
chain reaction on adjacent sections. 
Conclusions. This study refutes the premise that VZV is 
casually related to AION with and without giant cell arteritis.
Keywords.  anterior ischemic optic neuropathy; giant cell 
arteritis; immunohistochemistry nonspecific staining; temporal 
arterial biopsies; varicella-zoster virus.
Ischemic optic neuropathy is a sight-threatening disease that 
generally affects the optic nerve head (anterior ischemic optic 
neuropathy [AION]) [1]. Anterior ischemic optic neuropathy is 
the most common cause of acute optic nerve damage in individ-
uals >50 years old, with an annual incidence of 2–10 cases per 
100 000 persons. The vast majority of AION cases are idiopathic, 
but some specific etiologies reported are optic disc drusen, 
sleep apnea syndrome, medication, and general vascular risk 
factors [1]. The disease is typically divided into patients with 
and without vasculitis, usually giant cell arteritis (GCA) based 
on clinical symptoms such as headache and jaw claudication. 
Prompt diagnosis of arteritic AION is critical, because GCA 
may cause irreversible ischemic damage to the fellow eye, brain, 
and even the heart [1, 2]. A temporal artery biopsy (TAB) with 
mononuclear cell infiltrate and granulomatous inflammation is 
considered the gold standard for GCA diagnosis [1, 2].
Giant cell arteritis is an alleged, antigen-driven inflammation 
of medium to large arteries with several genetic and epidemio-
logic features suggesting a connection to an infectious agent [2, 
3]. Multiple hypotheses are being pursued, including one raised 
more recently in which varicella-zoster virus (VZV) infection 
of the arteries contributes to the inflammatory cascade [2–5]. 
Initial studies described widespread presence of VZV protein 
and/or deoxyribonucleic acid (DNA) in the majority GCA cases, 
as well as in TABs from patients with clinically suspected GCA 
but pathologically negative biopsy results [4, 5]. However, subse-
quent reports by other groups could not replicate these findings 
[3, 6–11]. Discrepancies may be due to the VZV antigen assayed, 
VZV glycoprotein E (VZV-gE) was commonly assayed in earlier 
studies showing strong VZV-GCA association, and the relative 
low number of sections stained per TAB [4, 5]. Indeed, similar 
to GCA pathophysiology [2], VZV infection may be focal and 
therefore requires detailed in situ analysis of a large number of 
serial sections spanning most of the TAB [3–5].
The aim of our retrospective study was to support or refute 
the VZV-AION, and particularly the GCA-VZV association, by 
performing well standardized immunohistochemistry (IHC), 
including the use of tissue microarrays (TMAs) with automated 
IHC targeting VZV-gE expression in large numbers of consec-
utive sections of 38 AION cases. Positive VZV-gE stainings, 
indicative for VZV infection, were corroborated by IHC and 
real-time polymerase chain reaction (PCR) analysis for detec-
tion of VZV immediate-early protein 63 (VZV-IE63) and VZV 
DNA in adjacent TAB sections, respectively.
METHODS
Specimens
Formalin-fixed and paraffin-embedded (FFPE) temporal artery 
biopsies obtained for diagnostic purposes of 38 AION patients, 
treated on suspicion of temporal arteritis between 1988 and 
2014 at the Department of Ophthalmology of Erasmus Medical 
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Center (EMC) and Rotterdam Eye Hospital (both in Rotterdam, 
The Netherlands), were provided by the EMC Tissue Bank 
(Supplementary Table 1). The study was performed according 
to the Declaration of Helsinki, and material was obtained in ac-
cordance with institutional regulations. Classic histopathological 
parameters, including granulomatous inflammation with giant 
cells and destruction of lamina elastica interna, were evaluated 
by routine hematoxylin/eosin and elastin staining [2, 3]. Two 
TMA blocks were constructed from one to four 5-mm core sam-
ples containing complete FFPE specimens of all 38 cases. Two 
thirds of TABs were too long and were split in 2 or even 4 parts 
that were all included in the TMAs (Supplementary Table 1). 
Approximately 215 serial 4-μm sections were cut from each TMA 
block, hereby completely processing the embedded biopsies.
Immunohistochemistry
In situ analysis was performed with an automated IHC staining 
system (Ventana BenchMark ULTRA; Ventana Medical 
Systems) using the diaminobenzidine method for all mouse 
monoclonal antibodies (mAbs) as a brown chromogen. In brief, 
after deparaffinization and heat-induced antigen retrieval using 
Cell Conditioning Solution 1 (Ventana Medical Systems) for 
64 minutes at 97oC, sections were incubated for 1 hour at 36oC 
with predefined concentration of VZV-gEs reactive mAb (clone 
MAB8612, Millipore; Chemicon, lot number 2526705, dilu-
tion 1:500). A  subsequent amplification step was followed by 
hematoxylin-counterstain and finally Bluing Reagent according 
to the manufacturer’s instructions (Ventana Medical Systems). 
Every third slide was stained for VZV-gE, hereby retaining 
consecutive sections for DNA isolation for VZV-specific PCR 
analysis or additional IHC stainings to detect VZV-IE63 (clone 
9D12, dilution 1:1000 [12]; a gift from Prof. Dr. Sadzot-Delvaux, 
University of Liege, Liege, Belgium), CD3 (T-cell marker [clone 
2GV6; Ventana]), or tryptase (mast cell marker [clone G3; Cell 
Marque]) [13]. Formalin-fixed and paraffin-embedded skin 
sections of an herpes zoster patient, obtained from the EMC 
Tissue Bank, were used as positive control. Positive VZV an-
tigen staining was considered if this was observed in at least 2 
serial sections stained for VZV-gE and subsequently confirmed 
with VZV-IE63 IHC on consecutive sections.
RESULTS
All 38 patients presented to an ophthalmologist with clinical 
signs of AION, 19 patients (50%) of which also developed typ-
ical vasculitic AION-associated headache. All patients met the 
American College of Rheumatology 1990 classification criteria 
for GCA [1, 2]. Mean age at presentation was 73 years (range, 
45–91 years) and 23 (61%) patients were female (Supplementary 
Table 1).
Ten of 38 TAB (26%) showed GCA at initial histopatho-
logical evaluation. To confer standardization in both tissue 
processing and IHC stainings, we constructed 2 TMA blocks, 
which contained core TAB specimens of all 38 AION cases, and 
used the Ventana BenchMark ULTRA automated IHC system 
to facilitate controlled in situ analysis, respectively. The mean 
number serial slides available for IHC per TAB was 438 (range, 
216–864 sections). After careful re-examination, we identified 4 
additional TABs with typical focal GCA lesions (Supplementary 
Table 1), which underscores and the well described low inci-
dence of temporal arteritis in clinically suspected cases that 
warrants extensive sectioning of TABs [2, 3].
To detect VZV infection in TAB of 38 AION patients, every 
third section of each TAB section series was stained with a com-
mercially available VZV-gE-specific mAb, which first was opti-
mized and validated in the automated IHC system on herpes 
zoster FFPE skin sections, which also included healthy skin 
as internal control tissue (Supplementary Figure 1). In total, 
5472 sections were stained for VZV-gE, with an average of 146 
TAB sections (range, 72–288) per AION patient. Four of 38 
TABs (10.5%), including 2 AION cases with GCA and 1 case 
that showed an arteritis lesion only after complete sectioning, 
showed focal VZV-gEpos IHC staining in at least 2 consecu-
tive sections. For 2 cases, this was localized mainly in smooth 
muscle cells of both arterial media and adventitial vessels in a 
maximum of 4 consecutive sections in a pattern similar to what 
has been reported positive in earlier publications (Figure 1 and 
Supplementary Table 1) [5–8]. Staining in myocytes appeared in 
a patchy distribution, and staining intensity and number of pos-
itive cells varied extensively both at the inter- and intraspecimen 
level. Such patchy expression may reflect a false-positive result, 











Figure 1. Immunohistochemical staining for varicella-zoster virus (VZV) protein 
expression in temporal arterial biopsies of 2 anterior ischemic optic neuropathy 
(AION) patients. Consecutive sections (4 µm) of AION patient no. 4 (top panels) and 
no. 5 (bottom panels; see Supplementary Table 1) were stained with mouse mon-
oclonal antibodies direct to VZV glycoprotein E (gE) and immediate-early protein 
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potentially due to tissue dehiscence during staining, and the 
fact that staining was seen without surrounding inflammatory 
response supported this impression (Figure 1) [4, 7, 8]. We also 
observed apparent false-positive VZV-gE staining of spindle-
like cells in the adventitial layer of 2 other TABs with dense in-
flammatory cell infiltrates containing mast cells (Figure 2). This 
second VZV-gE staining pattern was observed in all sections 
containing the inflammatory infiltrates.
To unequivocally confirm VZV infection in the TABs of 
the 4 VZV-gEpos AION cases, we performed IHC on consec-
utive TMA sections using an anti-VZV-IE63 mAb [12]. Using 
this anti-VZV mAb, however, no positive VZV-IE63 staining 
was observed (Figure  2). Finally, we performed VZV-specific 
TaqMan analysis on DNA recovered from consecutive sections 
at the same anatomic level of the respective TABs showing 
positive VZV-gE IHC staining (Supporting Methods Text). 
Whereas the single-copy housekeeping gene HMBS was readily 
detected, VZV DNA could not be detected by the highly sensi-
tive VZV-specific TaqMan assay (Supplementary Table 2). It is 
notable that both the VZV-IE63 and -gE IHC, and VZV- and 
HMBS-specific TaqMan assays, on human herpes zoster and 
control skin tissues showed IHC and TaqMan data as expected 
(Supplementary Tables 1 and 2 and Supplementary Figure 1).
DISCUSSION
Varicella-zoster virus vasculopathy and subsequently arterial 
ischemic stroke is hypothesized to be caused by reactivation of 
latent VZV in innervating neurons, followed by anterograde ax-
onal spread and productive VZV infection of cerebral arteries, 
which leads to a local inflammatory response [4–6]. Clinical 
signs and symptoms caused by VZV vasculopathy resemble 
those of AION, especially arteritic AION, suggesting an analo-
gous role of arterial VZV infection in AION pathogenesis [1, 2]. 
Indeed, VZV antigen has been detected by IHC in affected ar-
teries of GCA-negative TABs of 7 AION patients [14]. Moreover, 
earlier reports describing the high prevalence of VZV protein in 
both GCA-positive (73 of 104 cases, 70%) and -negative TABs 
(58 of 100 cases, 58%) and even autopsy-obtained control TABs 
(11 of 61 specimens, 18%) are of potential clinical relevance [4, 
5], but its association is still under debate and warrants confir-
mation [3, 6–11].
The current study was designed to meet the criticism raised 
on correctly detecting VZV infection in TABs of clinically sus-
pect cases with temporal arteritis: (1) we included TABs of 38 
(non-)arteritic well defined AION cases, (2) TABs were sec-
tioned completely for meticulous in situ analysis of which (3) 
every third section was stained for the abundant lytic viral 
VZV-gE protein (on average 146 serial sections/TAB), and 
(4) we performed confirmatory IHC for VZV-IE63 and VZV-
specific PCR analysis on consecutive sections of suspect VZV-
gEpos TABs, hereby enabling a comprehensive analysis of VZV 
infection throughout the complete TABs [3–11]. Furthermore, 
we generated 2 TMAs encompassing all 38 TABs, including a 
herpes zoster skin lesion as positive control, facilitating con-
trolled IHC analysis using a validated automated IHC staining 
system that limits inter-IHC assay variation. In our opinion, 
this approach is least likely to cause staining artifacts.
The VZV-gE expression in TABs of 4 of 38 AION cases sug-
gested productive infection, which, however, could not be con-
firmed by IHC for VZV-IE63 and VZV-specific PCR analysis 
on consecutive sections. Two types of false-positive VZV-gE 
staining patterns were observed. The first one was a patchy 
VZV-gE IHC signal mainly in smooth muscle cells, of both 
arterial media and adventitial vessels, and no clear membrane 
VZV-gE staining reflecting a truly lytic VZV-infected cell was 
observed [3–5, 14]. Similar staining patterns have been de-
scribed earlier by others and also considered false positive, 
especially because nonspecific antibody binding is commonly 
observed in smooth and skeletal muscle cells [6, 7, 10]. The 
second type of VZV-gE staining pattern appeared more like 
VZV-infected cells in situ, individual spindle-like cells with 
strong membranous staining, and was detected at sites of dense 
inflammation. Close examination of the inflammatory cell 
types revealed the presence of mast cells at the same location. 
More specifically, the VZV-gE signal frequently overlapped 
that of individual mast cells stained for in consecutive sections. 
Mast cells may contribute to temporal arteritis by stimulating 
the pathogenic effector functions of infiltrating inflammatory 
cells but also promote neovascularization [2, 3]. Nonspecific 
staining of mast cells by IHC is common and may involve non-
specific antibody binding to Fc receptors or heparin contained 
A B
C D
Figure 2. Immunohistochemical staining for varicella-zoster virus (VZV) protein 
expression in a temporal artery biopsy of a anterior ischemic optic neuropathy 
(AION) patient overlaps with mast cell infiltrate. Consecutive sections (4 µm) of 1 
AION case (patient no. 24) were stained for VZV glycoprotein E (A), tryptase (mast 
cell marker [B]), VZV immediate-early protein 63 (IE63 [C]), and CD3 (T-cell marker 
[D]). Positive staining signals are in brown color and insets are enlargements of the 
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within mast cell granules [15]. The Ventana detection system 
does not use biotin/streptavidin, ruling out endogenous biotin 
as a reason for nonspecific staining results [15].
CONCLUSIONS
In conclusion, this study describes a comprehensive and well 
controlled in situ analysis on TABs of a large cohort of AION 
cases that refutes the hypothesis that arterial VZV infection 
contributes to AION pathogenesis, both with and without 
GCA [2, 4]. Our data add to recent investigations from mul-
tiple laboratories worldwide (including United States, Canada, 
Australia, Sweden, Denmark, Spain, Italy, and United Kingdom) 
that all failed to reproduce the suspected association of VZV 
reactivation in temporal arteritis [3, 7–11]. Care in practice 
and interpretation of in situ methodologies are key for cor-
rect diagnosing and proving pathogenic involvement and, ul-
timately, to ensure correct treatment of patients with temporal 
arteritis including AION [1–3]. It is clear that a consensus on 
the association between VZV and temporal arteritis is crucial 
not only to determine the virus’ impact on disease but also for 
diagnostic pathology in general [2, 3]. An international work-
shop involving multiple laboratories sharing materials and 
methods is warranted to fulfill the unmet medical need for con-
sensus in the field.
Supplementary Data
Supplementary materials are available at The Journal of Infectious 
Diseases online. Consisting of data provided by the authors to 
benefit the reader, the posted materials are not copyedited and 
are the sole responsibility of the authors, so questions or com-
ments should be addressed to the corresponding author.
Supplementary Figure 1. Immunohistochemical staining for 
VZV protein expression in a skin biopsy from a herpes zoster 
patient. Consecutive skin sections of a herpes zoster lesion and 
adjacent health skin were stained for expression of VZV glyco-
protein E ([gE] A and C) and immediate-early protein 63 (IE63) 
(B and D), respectively. Positive staining signals are in brown 
color and original magnification was ×100.
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